{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T04:33:58Z","timestamp":1778733238275,"version":"3.51.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2006,3,13]],"date-time":"2006-03-13T00:00:00Z","timestamp":1142208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,3,13]],"date-time":"2006-03-13T00:00:00Z","timestamp":1142208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2006,5,1]]},"DOI":"10.1038\/sj.bmt.1705340","type":"journal-article","created":{"date-parts":[[2006,3,13]],"date-time":"2006-03-13T06:26:35Z","timestamp":1142231195000},"page":"857-864","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":92,"title":["Iron overload is a major risk factor for severe infection after autologous stem cell transplantation: a study of 367 myeloma patients"],"prefix":"10.1038","volume":"37","author":[{"given":"M H","family":"Miceli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M L","family":"Grazziutti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Fassas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Thertulien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Van Rhee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Barlogie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E J","family":"Anaissie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,3,13]]},"reference":[{"key":"BF1705340_CR1","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/01.moh.0000182836.40779.e7","volume":"12","author":"G Gahrton","year":"2005","unstructured":"Gahrton G . Progress in hematopoietic stem cell transplantation in multiple myeloma. Curr Opin Hematol 2005; 12: 463\u2013470.","journal-title":"Curr Opin Hematol"},{"key":"BF1705340_CR2","unstructured":"Barlogie B, Tricot G, Anaissie E, Shaughnessy J, Rasmussen E, van Rhee F et al. Effect of adding thalidomide to the treatment of multiple myeloma with tandem autotransplants. N Engl J Med 2006 (in press)."},{"key":"BF1705340_CR3","unstructured":"Anaissie E, Jacobson J, Fassas A, Zangari M, Thertulien R, van Rhee F et al. Safety of total therapy II with or without thalidomide (THAL) for newly diagnosed myeloma: a study of 475 consecutive patients. In: 45th American Society of Hematology Annual Meeting 2003; 6 December 2003; San Diego, 2003."},{"key":"BF1705340_CR4","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/sj.bmt.1702066","volume":"24","author":"JA Perez-Simon","year":"1999","unstructured":"Perez-Simon JA, Martin A, Caballero D, Corral M, Nieto MJ, Gonzalez M et al. Clinical significance of CD34+ cell dose in long-term engraftment following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 1999; 24: 1279\u20131283.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705340_CR5","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/BF02982583","volume":"76","author":"K Fujii","year":"2002","unstructured":"Fujii K, Aoyama M, Shinagawa K, Matsuo K, Takenaka K, Ikeda K et al. Risk of neutropenic fever and early infectious complications after autologous peripheral blood stem cell transplantation for malignant diseases. Int J Hematol 2002; 76: 186\u2013191.","journal-title":"Int J Hematol"},{"key":"BF1705340_CR6","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1182\/asheducation-2003.1.438","volume":"1","author":"SN O\u2019Brien","year":"2003","unstructured":"O\u2019Brien SN, Blijlevens NM, Mahfouz TH, Anaissie EJ . Infections in patients with hematological cancer: recent developments. Hematology (Am Soc Hematol Educ Program) 2003; 1: 438\u2013472.","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"key":"BF1705340_CR7","first-page":"39","volume-title":"Transplant Infections","author":"E Anaissie","year":"2003","unstructured":"Anaissie E, Nucci M . Risks and epidemiology of infections after autologous stem cell transplantation. In: Bowden RA, Ljungman P, Paya CV (eds). Transplant Infections, 2nd edn. Lippincott Williams & Wilkins: Philadelphia, 2003, pp 39\u201350."},{"key":"BF1705340_CR8","first-page":"355","volume":"18","author":"JD Nosanchuk","year":"1996","unstructured":"Nosanchuk JD, Sepkowitz KA, Pearse RN, White MH, Nimer SD, Armstrong D . Infectious complications of autologous bone marrow and peripheral stem cell transplantation for refractory leukemia and lymphoma. Bone Marrow Transplant 1996; 18: 355\u2013359.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705340_CR9","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1086\/515103","volume":"28","author":"EA Engels","year":"1999","unstructured":"Engels EA, Ellis CA, Supran SE, Schmid CH, Barza M, Schenkein DP et al. Early infection in bone marrow transplantation: quantitative study of clinical factors that affect risk. Clin Infect Dis 1999; 28: 256\u2013266.","journal-title":"Clin Infect Dis"},{"key":"BF1705340_CR10","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0002-9343(98)00409-4","volume":"106","author":"N Ketterer","year":"1999","unstructured":"Ketterer N, Espinouse D, Chomarat M, Dumontet C, Moullet I, Rieux C et al. Infections following peripheral blood progenitor cell transplantation for lymphoproliferative malignancies: etiology and potential risk factors. Am J Med 1999; 106: 191\u2013197.","journal-title":"Am J Med"},{"key":"BF1705340_CR11","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1086\/318491","volume":"32","author":"T Barton","year":"2001","unstructured":"Barton T, Collis T, Stadtmauer E, Schuster M . Infectious complications the year after autologous bone marrow transplantation or peripheral stem cell transplantation for treatment of breast cancer. Clin Infect Dis 2001; 32: 391\u2013395.","journal-title":"Clin Infect Dis"},{"key":"BF1705340_CR12","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/0196-6553(88)90053-3","volume":"16","author":"JS Garner","year":"1988","unstructured":"Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM . CDC definitions for nosocomial infections. Am J Infect Control 1988; 16: 128\u2013140.","journal-title":"Am J Infect Control"},{"key":"BF1705340_CR13","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1053\/beha.2002.0001","volume":"15","author":"JJ Marx","year":"2002","unstructured":"Marx JJ . Iron and infection: competition between host and microbes for a precious element. Best Pract Res Clin Haematol 2002; 15: 411\u2013426.","journal-title":"Best Pract Res Clin Haematol"},{"key":"BF1705340_CR14","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1182\/asheducation-2003.1.40","volume":"1","author":"E Beutler","year":"2003","unstructured":"Beutler E, Hoffbrand AV, Cook JD . Iron deficiency and overload. Hematology (Am Soc Hematol Educ Program) 2003; 1: 40\u201361.","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"key":"BF1705340_CR15","doi-asserted-by":"crossref","unstructured":"National Nosocomial Infections Surveillance (NNIS). National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992\u2013April 2000, issued June 2000. Am J Infect Control 2000; 28: 429\u2013448.","DOI":"10.1067\/mic.2000.110544"},{"key":"BF1705340_CR16","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.femsim.2004.11.010","volume":"43","author":"JJ Bullen","year":"2005","unstructured":"Bullen JJ, Rogers HJ, Spalding PB, Ward CG . Iron and infection: the heart of the matter. FEMS Immunol Med Microbiol 2005; 43: 325\u2013330.","journal-title":"FEMS Immunol Med Microbiol"},{"key":"BF1705340_CR17","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/nrmicro1046","volume":"2","author":"UE Schaible","year":"2004","unstructured":"Schaible UE, Kaufmann SH . Iron and microbial infection. Nat Rev Microbiol 2004; 2: 946\u2013953.","journal-title":"Nat Rev Microbiol"},{"issue":"4 Suppl 2","key":"BF1705340_CR18","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1053\/ajkd.1999.v34.aajkd0344b0025","volume":"34","author":"G Sunder-Plassmann","year":"1999","unstructured":"Sunder-Plassmann G, Patruta SI, Horl WH . Pathobiology of the role of iron in infection. Am J Kidney Dis 1999; 34 (4 Suppl 2): S25\u2013S29.","journal-title":"Am J Kidney Dis"},{"issue":"4 Suppl 2","key":"BF1705340_CR19","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1053\/ajkd.1999.v34.aajkd0344b0030","volume":"34","author":"B Hoen","year":"1999","unstructured":"Hoen B . Iron and infection: clinical experience. Am J Kidney Dis 1999; 34 (4 Suppl 2): S30\u2013S34.","journal-title":"Am J Kidney Dis"},{"key":"BF1705340_CR20","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1054\/mehy.2001.1368","volume":"57","author":"TD Clark","year":"2001","unstructured":"Clark TD, Semba RD . Iron supplementation during human immunodeficiency virus infection: a double-edged sword? Med Hypotheses 2001; 57: 476\u2013479.","journal-title":"Med Hypotheses"},{"key":"BF1705340_CR21","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1080\/003655201750313450","volume":"36","author":"TK Bergmann","year":"2001","unstructured":"Bergmann TK, Vinding K, Hey H . Multiple hepatic abscesses due to Yersinia enterocolitica infection secondary to primary haemochromatosis. Scand J Gastroenterol 2001; 36: 891\u2013895.","journal-title":"Scand J Gastroenterol"},{"key":"BF1705340_CR22","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1080\/003655201750066004","volume":"36","author":"M Hopfner","year":"2001","unstructured":"Hopfner M, Nitsche R, Rohr A, Harms D, Schubert S, Folsch UR . Yersinia enterocolitica infection with multiple liver abscesses uncovering a primary hemochromatosis. Scand J Gastroenterol 2001; 36: 220\u2013224.","journal-title":"Scand J Gastroenterol"},{"key":"BF1705340_CR23","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1023\/B:BIOM.0000018375.20026.b3","volume":"17","author":"S Moalem","year":"2004","unstructured":"Moalem S, Weinberg ED, Percy ME . Hemochromatosis and the enigma of misplaced iron: implications for infectious disease and survival. Biometals 2004; 17: 135\u2013139.","journal-title":"Biometals"},{"key":"BF1705340_CR24","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1086\/378062","volume":"37","author":"SC Wang","year":"2003","unstructured":"Wang SC, Lin KH, Chern JP, Lu MY, Jou ST, Lin DT et al. Severe bacterial infection in transfusion-dependent patients with thalassemia major. Clin Infect Dis 2003; 37: 984\u2013988.","journal-title":"Clin Infect Dis"},{"key":"BF1705340_CR25","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/sj.bmt.1701885","volume":"24","author":"J Maertens","year":"1999","unstructured":"Maertens J, Demuynck H, Verbeken EK, Zachee P, Verhoef GE, Vandenberghe P et al. Mucormycosis in allogeneic bone marrow transplant recipients: report of five cases and review of the role of iron overload in the pathogenesis. Bone Marrow Transplant 1999; 24: 307\u2013312.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705340_CR26","first-page":"EIM13","volume":"88","author":"N Kubota","year":"2003","unstructured":"Kubota N, Miyazawa K, Shoji N, Sumi M, Nakajima A, Kimura Y et al. A massive intraventricular thrombosis by disseminated mucormycosis in a patient with myelodysplastic syndrome during deferoxamine therapy. Haematologica 2003; 88: EIM13.","journal-title":"Haematologica"},{"key":"BF1705340_CR27","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1111\/j.1348-0421.2000.tb02577.x","volume":"44","author":"LI Hor","year":"2000","unstructured":"Hor LI, Chang YK, Chang CC, Lei HY, Ou JT . Mechanism of high susceptibility of iron-overloaded mouse to Vibrio vulnificus infection. Microbiol Immunol 2000; 44: 871\u2013878.","journal-title":"Microbiol Immunol"},{"key":"BF1705340_CR28","doi-asserted-by":"publisher","first-page":"358","DOI":"10.4269\/ajtmh.1998.58.358","volume":"58","author":"PE Thuma","year":"1998","unstructured":"Thuma PE, Olivieri NF, Mabeza GF, Biemba G, Parry D, Zulu S et al. Assessment of the effect of the oral iron chelator deferiprone on asymptomatic Plasmodium falciparum parasitemia in humans. Am J Trop Med Hyg 1998; 58: 358\u2013364.","journal-title":"Am J Trop Med Hyg"},{"key":"BF1705340_CR29","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S1386-6532(00)00135-9","volume":"20","author":"MS Gomes","year":"2001","unstructured":"Gomes MS, Boelaert JR, Appelberg R . Role of iron in experimental Mycobacterium avium infection. J Clin Virol 2001; 20: 117\u2013122.","journal-title":"J Clin Virol"},{"key":"BF1705340_CR30","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1086\/516481","volume":"175","author":"A Mencacci","year":"1997","unstructured":"Mencacci A, Cenci E, Boelaert JR, Bucci P, Mosci P, Fe d\u2019Ostiani C et al. Iron overload alters innate and T helper cell responses to Candida albicans in mice. J Infect Dis 1997; 175: 1467\u20131476.","journal-title":"J Infect Dis"},{"key":"BF1705340_CR31","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/sj.bmt.1701301","volume":"22","author":"SI Strasser","year":"1998","unstructured":"Strasser SI, Kowdley KV, Sale GE, McDonald GB . Iron overload in bone marrow transplant recipients. Bone Marrow Transplant 1998; 22: 167\u2013173.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705340_CR32","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/sj.bmt.1704628","volume":"34","author":"A Altes","year":"2004","unstructured":"Altes A, Remacha AF, Sarda P, Sancho FJ, Sureda A, Martino R et al. Frequent severe liver iron overload after stem cell transplantation and its possible association with invasive aspergillosis. Bone Marrow Transplant 2004; 34: 505\u2013509.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705340_CR33","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/sj.bmt.1703570","volume":"29","author":"A Altes","year":"2002","unstructured":"Altes A, Remacha AF, Sureda A, Martino R, Briones J, Canals C et al. Iron overload might increase transplant-related mortality in haematopoietic stem cell transplantation. Bone Marrow Transplant 2002; 29: 987\u2013989.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705340_CR34","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1128\/AAC.46.6.1741-1745.2002","volume":"46","author":"B Lesic","year":"2002","unstructured":"Lesic B, Foulon J, Carniel E . Comparison of the effects of deferiprone versus deferoxamine on growth and virulence of Yersinia enterocolitica. Antimicrob Agents Chemother 2002; 46: 1741\u20131745.","journal-title":"Antimicrob Agents Chemother"},{"key":"BF1705340_CR35","first-page":"1003","volume-title":"Cecil Textbook of Medicine","author":"T Duffy","year":"2004","unstructured":"Duffy T . Microcytic and hypochromic anemias. In: Goldman Lee AD (ed). Cecil Textbook of Medicine, 22nd edn. Saunders: Philadelphia, 2004, pp 1003\u20131009."},{"key":"BF1705340_CR36","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1001\/archinte.164.20.2206","volume":"164","author":"L Arcavi","year":"2004","unstructured":"Arcavi L, Benowitz NL . Cigarette smoking and infection. Arch Intern Med 2004; 164: 2206\u20132216.","journal-title":"Arch Intern Med"},{"key":"BF1705340_CR37","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1086\/339215","volume":"34","author":"WT Hughes","year":"2002","unstructured":"Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002; 34: 730\u2013751.","journal-title":"Clin Infect Dis"},{"key":"BF1705340_CR38","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1038\/sj.leu.2402495","volume":"16","author":"JH Rex","year":"2002","unstructured":"Rex JH, Anaissie EJ, Boutati E, Estey E, Kantarjian H . Systemic antifungal prophylaxis reduces invasive fungal in acute myelogenous leukemia: a retrospective review of 833 episodes of neutropenia in 322 adults. Leukemia 2002; 16: 1197\u20131199.","journal-title":"Leukemia"},{"key":"BF1705340_CR39","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1365-2141.2004.04851.x","volume":"125","author":"G Tricot","year":"2004","unstructured":"Tricot G, Barlogie B, Van Rhee F . Treatment advances in multiple myeloma. Br J Haematol 2004; 125: 24\u201330.","journal-title":"Br J Haematol"},{"issue":"Suppl 2","key":"BF1705340_CR40","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1038\/sj.bmt.1701668","volume":"23","author":"AL Pecora","year":"1999","unstructured":"Pecora AL . Impact of stem cell dose on hematopoietic recovery in autologous blood stem cell recipients. Bone Marrow Transplant 1999; 23 (Suppl 2): S7\u2013S12.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705340_CR41","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1046\/j.1365-2141.2000.02202.x","volume":"110","author":"AM Wardley","year":"2000","unstructured":"Wardley AM, Jayson GC, Swindell R, Morgenstern GR, Chang J, Bloor R et al. Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue. Br J Haematol 2000; 110: 292\u2013299.","journal-title":"Br J Haematol"},{"key":"BF1705340_CR42","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0140-6736(04)15436-6","volume":"363","author":"Y Gandon","year":"2004","unstructured":"Gandon Y, Olivie D, Guyader D, Aube C, Oberti F, Sebille V et al. Non-invasive assessment of hepatic iron stores by MRI. Lancet 2004; 363: 357\u2013362.","journal-title":"Lancet"},{"key":"BF1705340_CR43","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1056\/NEJM200003093421002","volume":"342","author":"JP Nuorti","year":"2000","unstructured":"Nuorti JP, Butler JC, Farley MM, Harrison LH, McGeer A, Kolczak MS et al. Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. N Engl J Med 2000; 342: 681\u2013689.","journal-title":"N Engl J Med"},{"key":"BF1705340_CR44","volume-title":"Neoplastic Disease of the Blood","author":"C Dignani","year":"2003","unstructured":"Dignani C, Mahfouz M, EJ A . Prevention of infections in patients with hematologic malignancy. In: Wiernick G, Dutcher and Kyle (eds). Neoplastic Disease of the Blood, 4th edn. Cambridge University Press, North American Branch: Stanford, 2003."},{"key":"BF1705340_CR45","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/(SICI)1098-1101(2000)15:1\/2<28::AID-JCA4>3.0.CO;2-N","volume":"15","author":"KM Grima","year":"2000","unstructured":"Grima KM . Therapeutic apheresis in hematological and oncological diseases. J Clin Apher 2000; 15: 28\u201352.","journal-title":"J Clin Apher"},{"key":"BF1705340_CR46","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0955-3886(00)00042-4","volume":"22","author":"M Valbonesi","year":"2000","unstructured":"Valbonesi M, Bruni R . Clinical application of therapeutic erythrocytapheresis (TEA). Transfus Sci 2000; 22: 183\u2013194.","journal-title":"Transfus Sci"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1705340","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705340.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705340.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:44:17Z","timestamp":1648082657000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1705340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,13]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006,5,1]]}},"alternative-id":["BF1705340"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1705340","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,13]]},"assertion":[{"value":"5 September 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2006","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2006","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2006","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}